Radiation Oncologist, Co-founder & CEO, Fuse Biotherapeutics
Paul Y. Song, MD is a board-certified radiation oncologist and the co-founder and CEO of Fuse Biotherapeutics, a privately held biotechnology company focused on redirected immunotherapy in cancer.
He last practiced full-time at Cedars Sinai Medical Center. He currently volunteers at Dignity California Hospital where he sees Medicaid and uninsured patients.
Dr. Song served as the very first visiting fellow on healthcare policy in the California Department of Insurance in 2013.
Dr. Song graduated with honors from the University of Chicago and received his M.D. degree from George Washington University. He completed his residency in radiation oncology at the University of Chicago where he served as Chief Resident and did a brachytherapy fellowship at the Institute Gustave Roussy in Villejuif, France. He was also awarded an ASTRO research fellowship in 1995 for his research in radiation inducible gene therapy.
Dr. Song serves on the national board of Physicians for a National Health Program, Mercy Corps, The Pritzker School for Molecular Engineering, Progressive Democrats of America, and the Center for Health and Democracy.